Information  X 
Enter a valid email address
  Print          More announcements

Friday 02 July, 2021

Accustem Sciences

Distribution Dates for shares and ADRs in Accustem

RNS Number : 0389E
Accustem Sciences Limited
02 July 2021

Accustem Sciences Limited

("Accustem" or the "Company")

Distribution Dates for shares and ADRs in Accustem Sciences Limited

Accustem Sciences Limited is pleased to announce that the Forms 20-F and F-6 filed by Accustem Sciences Limited with the SEC were declared effective on 1 July 2021, enabling the completion of the in specie distribution and spin out of Accustem from Tiziana Life Sciences plc. The SEC filings can be viewed at and there is also a link to them on the Accustem website:

If you held ordinary shares in Tiziana Life Sciences plc ("Tiziana") on the UK Record Date

The timetable for the holders of Tiziana ordinary shares (traded on the London Stock Exchange) held in CREST and Certificated form is as follows:

Demerger Record Time:  7:00 a.m. on 30 October 2020

Ex-entitlement date for Accustem Shares:  2 November 2020

CREST accounts credited with Accustem Shares:  8 July 2021*

Certificates for Accustem Shares for those shareholders

holding their Tiziana Life Sciences plc in certificated form:  by 18 July 2021

* replacing allocation placeholders currently showing

If you held Tiziana ADSs (traded on the US Nasdaq Market) on the DR Record Date

The timetable for the holders of Tiziana ADSs (traded on the Nasdaq market) is set out below. You should also review the notice posted by JP Morgan, the ADR depositary bank, which can be found at

Announcement Tiziana CUSIP: 88875G101

Corporate Action Type:   Spin Off with DR Distribution

Spin Off Issuer Name:  Accustem Sciences Limited

Spin Off DR CUSIP:   00442Y101

DR Distribution Rate:          1 new Accustem DR(s) issued for every 1 existing Tiziana DR held on DR Record Date

Tax Withholding Rate:   n/a

DR Record Date:   November 6, 2020

DR Payment Date:   July 14, 2021

DR Issuance and Cancellation Books close Date: October 28, 2020

DR Issuance and Cancellation Books reopen Date: July 19, 2021

Fees: Issuance fee: $nil per DR issued

This will formally conclude the separation of Accustem from Tiziana Life Sciences plc and no further information concerning Accustem will be published on the Tiziana website. Regular updates will be posted to the Accustem website.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t